Filing Details

Accession Number:
0000899243-23-019661
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-10-02 20:55:40
Reporting Period:
2023-09-28
Accepted Time:
2023-10-02 20:55:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1635088 Roivant Sciences Ltd. ROIV Pharmaceutical Preparations (2834) 981173944
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1832142 Allen Daniel Gold C/O Roivant Sciences Ltd.
7Th Floor, 50 Broadway
London X0 SW1H 0DB
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2023-09-28 8,957 $11.55 100,804 No 4 S Indirect Held by Fourth Avenue Capital Partners LP
Common Shares Disposition 2023-09-28 2,285,783 $11.55 25,724,561 No 4 S Indirect Held by QVT Deferred Compensation Holdings Ltd
Common Shares Disposition 2023-09-28 3,059,368 $11.55 34,430,591 No 4 S Indirect Held by QVT Financial Investment Cayman Ltd.
Common Shares Disposition 2023-09-28 3,094,899 $11.55 34,830,463 No 4 S Indirect Held by QVT Roiv Hldgs Offshore Ltd
Common Shares Disposition 2023-09-28 1,104,599 $11.55 12,431,330 No 4 S Indirect Held by QVT Roiv Hldgs Onshore Ltd
Common Shares Disposition 2023-09-28 446,394 $11.55 5,023,787 No 4 S Indirect Held by QVT P&E Roiv Hldgs Ltd
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Held by Fourth Avenue Capital Partners LP
No 4 S Indirect Held by QVT Deferred Compensation Holdings Ltd
No 4 S Indirect Held by QVT Financial Investment Cayman Ltd.
No 4 S Indirect Held by QVT Roiv Hldgs Offshore Ltd
No 4 S Indirect Held by QVT Roiv Hldgs Onshore Ltd
No 4 S Indirect Held by QVT P&E Roiv Hldgs Ltd
Footnotes
  1. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.
  2. The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC.
  3. QVT Financial LP, a Delaware limited partnership, is the investment manager of QVT Roiv Hldgs Onshore Ltd. and QVT Roiv Hldgs Offshore Ltd. (together, "QVT Roiv"), and shares voting and investment control over the Shares held directly by QVT Roiv. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT Financial LP. The reporting person is a Managing Member of QVT Financial GP, sharing voting and investment control over the Common Shares held directly by QVT Roiv and may be deemed to beneficially own such Common Shares.
  4. The reporting person is one of two directors of QVT P&E Roiv Hldgs Ltd. ("QVT P&E") and QVT Deferred Compensation Holdings Ltd ("QVT DCH"), sharing voting and investment control over the Common Shares held directly by QVT P&E and QVT DCH.
  5. Management of Fourth Avenue Capital Partners LP is vested in its general partner, Fourth Avenue Capital Partners GP LLC, a Delaware limited liability company ("Fourth Avenue GP"), which may be deemed to beneficially own the Common Shares held directly by Fourth Avenue. Daniel Gold is a Managing Member of Fourth Avenue GP, sharing voting and investment control over the Common Shares held directly by Fourth Avenue and may be deemed to beneficially own such Common Shares.